Semaglutide

Generic Name: semaglutide

GLP-1 Receptor AgonistsPrescription Required

Brand Names:

Ozempic, Wegovy, Rybelsus

Semaglutide is a GLP-1 receptor agonist used for type 2 diabetes and chronic weight management.

Overview

Semaglutide is a GLP-1 receptor agonist used for type 2 diabetes and chronic weight management.

Uses

Type 2 diabetes mellitus, chronic weight management in adults with obesity.

Dosage

Ozempic: Start 0.25 mg weekly, escalate to 0.5 mg then 1–2 mg weekly.

Side Effects

Common: Nausea, vomiting, diarrhea, constipation, decreased appetite.

Interactions

Insulin and sulfonylureas — increased hypoglycemia risk. May affect oral medication absorption.

Warnings

FDA Black Box Warning: Thyroid C-cell tumors in animal studies. Monitor for pancreatitis.

Pregnancy

Not recommended — discontinue at least 2 months before planned pregnancy.

Storage

Injection pens: Refrigerate before first use. After first use, room temperature up to 56 days.

Frequently Asked Questions

What is Semaglutide used for?

Type 2 diabetes mellitus, chronic weight management in adults with obesity.

What are the side effects of Semaglutide?

Common: Nausea, vomiting, diarrhea, constipation, decreased appetite.

Can I take Semaglutide during pregnancy?

Not recommended — discontinue at least 2 months before planned pregnancy.

What are the important warnings for Semaglutide?

FDA Black Box Warning: Thyroid C-cell tumors in animal studies. Monitor for pancreatitis.

Related Medications

Medical Disclaimer

This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.